Lenskart IPO GMP Today

Introduction

The Indian IPO market is currently buzzing with activity. With multiple big issues entering the market simultaneously, investors are closely monitoring liquidity and subscription trends. Among the most talked-about listings is the Lenskart IPO GMP, which has triggered strong discussions regarding its valuation, fundamentals, and grey market movement.

What is Lenskart IPO GMP Today?

As of the latest updates, the Lenskart IPO GMP (Grey Market Premium) has seen a notable decline.

Earlier, the GMP was around ₹95 per share, indicating a 23.5% premium over the issue price.

However, the GMP has now dropped to ₹66 per share, suggesting a listing gain of approximately 16.5%.

This drop clearly reflects investor sentiment turning cautious amid high valuations and social media buzz questioning the company’s profitability.

Lenskart IPO Details

Particular Details

IPO Price Band ₹382 – ₹402 per share
Lot Size 37 shares per lot
Total Issue Size ₹7,278 crore
Fresh Issue ₹2,150 crore
Offer for Sale (OFS) ₹5,000 crore
Expected Listing Price Around ₹468 per share
GMP (Latest) ₹66 per share (16.5% premium expected)

Company Financials & Performance

Lenskart has shown strong revenue growth over the years, but its profitability remains inconsistent.

Year Profit / Loss (₹ Crore)

2023 -64 (Loss)
2024 -10 (Loss)
2025 (Projected) 298 (Profit)

Although the company turned profitable recently, analysts believe its valuation is extremely high compared to peers in the eyewear market.

Valuation Analysis

Experts have raised concerns about Lenskart’s expensive valuation:

P/E Ratio: ~234x (very high)

EV/EBITDA: 70x
This means investors are willing to pay ₹70 for every ₹1 of earnings — indicating overvaluation relative to industry standards.

Many analysts believe even if Lenskart triples its current profits, it still won’t justify these valuation levels.

Expert Opinions

Market experts, including Avinash Gorakshkar, have advised caution:

> “The valuation is extremely high, and investors should prioritize capital protection over speculative gains.”

 

Another analyst added:

> “Apply only if you have high-risk appetite or excess funds. Watch the QIB subscription data on the last IPO day — if it’s not oversubscribed 1.5x–2x, it’s safer to withdraw your application.”

 

Peer Comparison

In India’s organized eyewear segment, Titan Eye+ remains the strongest competitor. While Lenskart enjoys strong brand visibility, the overall eyewear market is still fragmented, limiting massive profitability growth potential.

Should You Apply for the Lenskart IPO?

Investor Type Recommendation

Low-risk investors Avoid (High valuation, uncertain premium)
High-risk investors Apply only on the last day after checking QIB data
Short-term traders Expect 5–10% listing gain potential
Long-term investors Wait for post-listing price correction

Final Verdict

While Lenskart is a strong consumer brand with expanding revenue, its current valuation multiples are not aligned with its profitability. The falling Lenskart IPO GMP further confirms investor hesitation. For most retail investors, avoiding this IPO might be a smarter choice until valuations normalize.

Related IPO Updates

Alongside Lenskart, other upcoming IPOs like Ockla India are also being tracked closely. However, even there, the GMP has dropped from 13% to around 8.7%, signaling reduced enthusiasm across the market.

 

FAQ: Lenskart IPO GMP

More